Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Cools

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Journal of Pharmacological and Toxicological Methods|January 4, 2015
Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testingVerena Gotta, Frank Cools, Karel van Ammel, et al.
Pharmacology Research & Perspectives|January 19, 2017
Application of a systems pharmacology model for translational prediction of hERG-mediated QTc prolongationVerena Gotta, Zhiyi Yu, Frank Cools, et al.
Research and Practice in Thrombosis and Haemostasis|December 19, 2024
Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsDavide Di Vece, Marco Valgimigli, Elliot Barnathan, et al.
International Journal of Cardiology|August 24, 2016
Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registrySeil Oh, Shinya Goto, Gabriele Accetta, et al.
Journal of Pharmacological and Toxicological Methods|July 15, 2020
Echocardiographic and hemodynamic indices of myocardial contractility simultaneously evaluated in telemetered beagle dogs: A HESI-sponsored cross-company evaluationEric I Rossman, Frank Cools, Jason Cordes, et al.
European Heart Journal|August 2, 2011
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomesRobert F Storey, Richard C Becker, Robert A Harrington, et al.
The New England Journal of Medicine|March 11, 2005
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevationMarc S Sabatine, Christopher P Cannon, C Michael Gibson, et al.
Open Heart|January 20, 2025
Emulation of ARISTOTLE and ROCKET AF trials in real-world atrial fibrillation patients results in similar efficacy and safety as original landmark trials: insights from the GARFIELD-AF registryJelle C L Himmelreich, Saverio Virdone, A John Camm, et al.
American Heart Journal|September 11, 2013
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trialEmmanouil S Brilakis, Claes Held, Bernhard Meier, et al.
The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Journal of Pharmacological and Toxicological Methods|January 4, 2015
Sensitivity of pharmacokinetic-pharmacodynamic analysis for detecting small magnitudes of QTc prolongation in preclinical safety testingVerena Gotta, Frank Cools, Karel van Ammel, et al.
Pharmacology Research & Perspectives|January 19, 2017
Application of a systems pharmacology model for translational prediction of hERG-mediated QTc prolongationVerena Gotta, Zhiyi Yu, Frank Cools, et al.
Research and Practice in Thrombosis and Haemostasis|December 19, 2024
Primary thromboprophylaxis in ambulatory symptomatic patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsDavide Di Vece, Marco Valgimigli, Elliot Barnathan, et al.
International Journal of Cardiology|August 24, 2016
Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registrySeil Oh, Shinya Goto, Gabriele Accetta, et al.
Journal of Pharmacological and Toxicological Methods|July 15, 2020
Echocardiographic and hemodynamic indices of myocardial contractility simultaneously evaluated in telemetered beagle dogs: A HESI-sponsored cross-company evaluationEric I Rossman, Frank Cools, Jason Cordes, et al.
European Heart Journal|August 2, 2011
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomesRobert F Storey, Richard C Becker, Robert A Harrington, et al.
The New England Journal of Medicine|March 11, 2005
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevationMarc S Sabatine, Christopher P Cannon, C Michael Gibson, et al.
Open Heart|January 20, 2025
Emulation of ARISTOTLE and ROCKET AF trials in real-world atrial fibrillation patients results in similar efficacy and safety as original landmark trials: insights from the GARFIELD-AF registryJelle C L Himmelreich, Saverio Virdone, A John Camm, et al.
American Heart Journal|September 11, 2013
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trialEmmanouil S Brilakis, Claes Held, Bernhard Meier, et al.
The American Journal of Cardiology|September 6, 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)Robert F Storey, Richard C Becker, Robert A Harrington, et al.
Pageof 4